Landscapes / Companies

Ocugen not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 3
1 in Phase 2
Next date
OCU400, Phase 1/2 trial completes
Drugs
4
in active trials · 7 in all
Trials
4 active
8 since 2021

Drugs4

DrugHow it worksPartnerStageNext dateDetails
—
Phase 3 30 Jul 2028Phase 3 trial completes
—
Phase 2/3 —
—
Phase 1/2 Mar 2027Phase 1/2 trial completes
—
Phase 1 —

About

No active trial
BBV152, Brimonidine Mono Therapy, Corticosteroid Eye Drop
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021

Follow Ocugen

Following is part of Solo: you see every change to Ocugen the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in